Literature DB >> 11875117

Direct regulation of beta3-integrin subunit gene expression by HOXA10 in endometrial cells.

Gaurang S Daftary1, Patrick J Troy, Catherine N Bagot, Steven L Young, Hugh S Taylor.   

Abstract

Estrogen and progesterone regulate HOXA10 expression in the endometrium, where HOXA10 is necessary for implantation. The integrins are also involved in early embryo-endometrial interactions. Here we show that HOXA10 directly regulates beta3-integrin subunit expression in the endometrium, likely mediating the effect of sex steroids on beta3-integrin expression. beta3-Integrin expression was decreased in endometrium shown to have low HOXA10 expression. beta3-Integrin mRNA levels were increased in endometrial adenocarcinoma cells (Ishikawa) transfected with pcDNA3.1/HOXA10, and decreased in cells treated with HOXA10 antisense. Seven consensus HOXA10 binding sites were identified 5' of the beta3-integrin gene. Direct binding of HOXA10 protein to four sites was demonstrated by EMSA. Reporter gene expression increased in BT-20 cells cotransfected with pcDNA3.1/ HOXA10 and pGL3-promoter vector containing region F (encompassing all seven HOXA10 consensus sites). A 41-bp segment (Region A) showed highest affinity binding to HOXA10 protein. Increased reporter expression, equal in magnitude to that obtained with Region F, was obtained with Region A. HOXA10 protein binding within Region A was localized by deoxyribonuclease I footprinting. beta3-Integrin expression was directly up-regulated by HOXA10 through a 41-bp 5'-regulatory element. Sex steroids regulate the expression of endometrial beta3-integrin through a pathway involving HOXA10.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11875117     DOI: 10.1210/mend.16.3.0792

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  68 in total

Review 1.  Transcriptional regulation of implantation by HOX genes.

Authors:  Hugh S Taylor
Journal:  Rev Endocr Metab Disord       Date:  2002-05       Impact factor: 6.514

2.  Transcriptional repression of peri-implantation EMX2 expression in mammalian reproduction by HOXA10.

Authors:  Patrick J Troy; Gaurang S Daftary; Catherine N Bagot; Hugh S Taylor
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

3.  Endothelin type A receptor (ETA) expression is regulated by HOXA10 in human endometrial stromal cells.

Authors:  Ivan A Penna; Amanda N Kallen; Hugh S Taylor
Journal:  Reprod Sci       Date:  2010-05       Impact factor: 3.060

4.  Environment and vascular bed origin influence differences in endothelial transcriptional profiles of coronary and iliac arteries.

Authors:  Kelley A Burridge; Morton H Friedman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-06-11       Impact factor: 4.733

Review 5.  Implantation failure: molecular mechanisms and clinical treatment.

Authors:  Hakan Cakmak; Hugh S Taylor
Journal:  Hum Reprod Update       Date:  2010-08-21       Impact factor: 15.610

6.  A novel role for the AAA ATPase spastin as a HOXA10 transcriptional corepressor in Ishikawa endometrial cells.

Authors:  Gaurang S Daftary; Amy M Tetrault; Elisa M Jorgensen; Jennifer Sarno; Hugh S Taylor
Journal:  Mol Endocrinol       Date:  2011-07-14

7.  Regulatory effect of estrogen, progestin and HB-EGF on the expression of HOXA10 gene in Ishikawa cells.

Authors:  Xuemei Liu; Guijin Zhu; Gang Zhong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-08

Review 8.  Endocrine disruptors affect developmental programming of HOX gene expression.

Authors:  Hugh S Taylor
Journal:  Fertil Steril       Date:  2008-02       Impact factor: 7.329

9.  Global analysis of genes regulated by HOXA10 in decidualization reveals a role in cell proliferation.

Authors:  Z Lu; J Hardt; J J Kim
Journal:  Mol Hum Reprod       Date:  2008-05-02       Impact factor: 4.025

10.  3-Phosphoglycerate dehydrogenase expression is regulated by HOXA10 in murine endometrium and human endometrial cells.

Authors:  Hongling Du; Danielle Vitiello; Jennifer L Sarno; Hugh S Taylor
Journal:  Reproduction       Date:  2010-01       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.